Celldex Therapeutics

About:

Celldex is a clinical stage company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases.

Website: http://celldex.com

Description:

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.

Total Funding Amount:

$1.54B

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hampton, New Jersey, United States

Founded Date:

1983-01-01

Contact Email:

info(AT)celldextherapeutics.com

Founders:

Anthony S. Marucci, Tibor Keler

Number of Employees:

101-250

Last Funding Date:

2024-02-29

IPO Status:

Public

© 2025 bioDAO.ai